Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
about
Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazoleThe management of gastro-oesophageal reflux diseaseA 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study.Esophagitis in children: an update on current pharmacotherapy.The stereoselectivity of CYP2C19 on R- and S-isomers of proton pump inhibitors.Proton pump inhibitor prescribing patterns in the UK: a primary care database study.Medical and non-medical predictors of initiating long-term use of proton pump inhibitors: a nationwide cohort study of first-time users during a 10-year period.Outcome after Discontinuation of Proton Pump Inhibitors at a Residential Care Site: Quality Improvement Project.Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppressionDéprescrire les inhibiteurs de la pompe à protons: Lignes directrices de pratique clinique fondées sur les données probantes.Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials.Study to determine the likely accuracy of pH testing to confirm nasogastric tube placement.The evaluation of three treatment protocols using oral prednisone and oral meloxicam for therapy of canine idiopathic lymphoplasmacytic rhinitis: a pilot study
P2860
Q26741015-535109B3-A781-4AF3-9F50-12291A9EB91FQ26753012-CEB0EF98-C22F-46D9-8C13-771C60CD7C6FQ30276528-58DD37AE-2B80-4E44-B7E9-EFF4CB8641D4Q33675495-8B20D15D-FE06-4F25-9C35-B44D55066555Q36285871-59E5B8D6-1B78-43C4-A111-1B922CE40CBEQ37173748-04579833-82ED-478B-B962-0A4E9EE12BD7Q38153767-56F23286-1422-402A-B07F-2C74C83A5D8CQ39292057-607A7FDB-B890-4937-BE8B-132F4BC171FCQ39714357-A6473706-EF9C-48C6-9A9F-3C91203C4BE1Q39801583-4CC1FEE8-3AC4-41CE-B76F-E36076D69A3CQ40146435-D819C8B3-ED7E-4A8F-BC71-092D902CFB80Q40655375-6604074D-4BF8-4E9F-A678-AB4FDC90D1ECQ42371575-CF6BB4C1-EB74-440C-8FA7-B6FFB78A0AA0Q46189430-F9DBA5BF-74C4-48D2-9D14-8EF716054E25Q55113683-50E40A6D-6C88-4174-AA2C-01E3DF6EFE62Q55266404-3A9917E5-05AE-4EEA-85D6-5F47C0EE64FBQ55276792-41797771-50E0-44AE-BDD4-C1E0A5A55E6CQ57298112-9576445C-840D-4F64-8644-CCBF19DCF1A0
P2860
Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review: symptoms of ...... oton pump inhibitor treatment.
@en
type
label
Systematic review: symptoms of ...... oton pump inhibitor treatment.
@en
prefLabel
Systematic review: symptoms of ...... oton pump inhibitor treatment.
@en
P2093
P2860
P1476
Systematic review: symptoms of ...... oton pump inhibitor treatment.
@en
P2093
Anders Bergh Lødrup
Christina Reimer
Peter Bytzer
P2860
P304
P356
10.3109/00365521.2012.746395
P577
2013-01-14T00:00:00Z